Why the next big hope for Alzheimer’s might not help most Black patients

BY: - July 13, 2023

The FDA last week gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the […]

FDA approves Alzheimer’s disease treatment under clinical trial at University of Kentucky

BY: - July 7, 2023

A key antibody treatment in the fight against Alzheimer’s disease, which the University of Kentucky has been studying, just got a full green light from the U.S. Food and Drug Administration.  The approval, which came out Thursday afternoon, means that many Kentuckians with mild cognitive impairment may enjoy an extension of their quality of life.  […]